pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 396 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Preclinical
    AQ-002
    Asthma Aquilon Pharmaceuticals SA
  • Preclinical
    AQ-003
    Chronic Obstructive Pulmonary Disease (COPD) Aquilon Pharmaceuticals SA
  • Preclinical
    ARBM-201
    Acute Respiratory Distress Syndrome Arbormed Co Ltd
  • Phase 2
← prev
page 5 of 14
next →
Pain89
Neurology1
ARCT-032
Cystic Fibrosis
$ARCT Arcturus Therapeutics Holdings Inc.
  • Preclinical
    ATLX–0199
    Unspecified Cardiovascular Disorders Atelerix Life Sciences Inc
  • Phase 2
    AV-0328
    Streptococcal Pneumonia Alopexx Inc
  • Preclinical
    AVG-002
    Unspecified Respiratory Disorders AlveoGene Ltd
  • Phase 2
    AZD-0292
    Bronchiectasis$AZN ASTRAZENECA PLC
  • Phase 1
    AZD-8965
    Idiopathic Pulmonary Fibrosis$AZN ASTRAZENECA PLC
  • Preclinical
    Anti-PD1 Antibody
    Lymphangioleiomyomatosis BioSputnik LLC
  • Preclinical
    Antibody Drug Conjugate for Idiopathic Pulmonary Fibrosis
    Idiopathic Pulmonary Fibrosis Bionevix Ltd
  • Marketed
    Augmentin
    Augmentin ((amoxicillin + clavulanate potassium))
    Skin And Skin Structure Infections (SSSI) Caused By Bacteria NeoPharma Inc
  • Phase 2
    BBT-877
    Idiopathic Pulmonary Fibrosis Parataxis Korea Inc
  • Phase 2
    BI-1819479
    Idiopathic Pulmonary Fibrosis Boehringer Ingelheim International GmbH
  • Phase 1
    BRS-101
    Idiopathic Pulmonary Fibrosis BreStem Therapeutics Inc
  • Phase 1
    BSI-502
    Atopic Dermatitis (Atopic Eczema)$ACRS Aclaris Therapeutics, Inc.
  • Marketed
    Bicillin L A
    Bicillin L A (penicillin G benzathine)
    Upper Respiratory Tract Infections by Streptococcus pyogenes$PFE PFIZER INC
  • Phase 2
    Broncho-Vaxom
    Wheezing OM Pharma Ltd
  • Preclinical
    C-867
    Asthma Raesedo Inc
  • Preclinical
    C-892
    Asthma Raesedo Inc
  • Phase 2
    CAL-02
    Community-Acquired Bacterial Pneumonia Eagle Pharmaceuticals Inc
  • Phase 2
    CAL-101
    Idiopathic Pulmonary Fibrosis Calluna Pharma AS
  • Preclinical
    CBM-301
    Idiopathic Pulmonary Fibrosis CellionBioMed Inc
  • Preclinical
    CEN-501
    Allergic Rhinitis NeuCen BioMed Co Ltd
  • Phase 2
    CHF-6333
    Bronchiectasis Chiesi Farmaceutici SpA
  • Phase 1
    CHF-6795
    Chronic Cough Chiesi Farmaceutici SpA
  • Preclinical
    CIL-05
    Primary Ciliary Dyskinesia Cila Therapeutics Inc
  • Phase 2
    CMTX-101
    Pseudomonas aeruginosa Infections Clarametyx Biosciences Inc
  • Preclinical
    CTX-002
    Coronavirus Disease 2019 (COVID-19) Associated Acute Resp… Ceria Therapeutics Inc
  • Phase 2
    CX-1739
    Central Sleep Apnea EndeavourRx LLC